Nothing Special   »   [go: up one dir, main page]

NO20000016L - Sykliske azapeptider med angiogen virkning - Google Patents

Sykliske azapeptider med angiogen virkning

Info

Publication number
NO20000016L
NO20000016L NO20000016A NO20000016A NO20000016L NO 20000016 L NO20000016 L NO 20000016L NO 20000016 A NO20000016 A NO 20000016A NO 20000016 A NO20000016 A NO 20000016A NO 20000016 L NO20000016 L NO 20000016L
Authority
NO
Norway
Prior art keywords
angiogenic activity
aarg
aasp
agly
azapeptides
Prior art date
Application number
NO20000016A
Other languages
English (en)
Other versions
NO20000016D0 (no
Inventor
Alfred Jonczyk
Simon Goodman
Horst Kessler
Jochen Wermuth
Joerg Schmitt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20000016L publication Critical patent/NO20000016L/no
Publication of NO20000016D0 publication Critical patent/NO20000016D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Forbindelser med formel (I) syklo-(aArg-aGly-aAsp-aX-aY), hvor aArg, aGly, aAsp, aX og aY har de i krav l angitte betydninger, samt deres salter, kan anvendes som integrininhi- bitorer, særlig til profylakse og be- handling av sykdommer i blodomløpet, ved trombose, hjerteinfarkt, koronare hjertesykdommer, arteriosklerose, ved patologiske tilstander som underholdes og propageres av angiogenese, og i tumorterapi.
NO20000016A 1997-07-04 2000-01-03 Sykliske azapeptider med angiogen virkning NO20000016D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19728524A DE19728524A1 (de) 1997-07-04 1997-07-04 Cyclische Azapeptide
PCT/EP1998/003955 WO1999001472A1 (de) 1997-07-04 1998-06-29 Cyclische azapeptide mit angiogener wirkung

Publications (2)

Publication Number Publication Date
NO20000016L true NO20000016L (no) 2000-01-03
NO20000016D0 NO20000016D0 (no) 2000-01-03

Family

ID=7834596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000016A NO20000016D0 (no) 1997-07-04 2000-01-03 Sykliske azapeptider med angiogen virkning

Country Status (20)

Country Link
US (1) US6534478B1 (no)
EP (1) EP1001979B1 (no)
JP (1) JP2002511872A (no)
KR (1) KR20010014267A (no)
CN (1) CN1261895A (no)
AR (1) AR010924A1 (no)
AT (1) ATE297947T1 (no)
AU (1) AU733831B2 (no)
BR (1) BR9810394A (no)
CA (1) CA2297181A1 (no)
DE (2) DE19728524A1 (no)
HU (1) HUP0003357A3 (no)
ID (1) ID23415A (no)
NO (1) NO20000016D0 (no)
PL (1) PL337616A1 (no)
RU (1) RU2188205C2 (no)
SK (1) SK173599A3 (no)
TW (1) TW482768B (no)
WO (1) WO1999001472A1 (no)
ZA (1) ZA985896B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
US6723722B1 (en) 1999-06-22 2004-04-20 Takeda Chemical Industries, Ltd. Acylhydrazine derivatives, their production and use
GB0217017D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 2
WO2008033557A2 (en) * 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclic peptidomimetics as integrin markers
EP2182974B1 (en) * 2007-07-27 2015-08-26 Siemens Medical Solutions USA, Inc. Cyclic azapeptides as integrin markers
WO2009134382A2 (en) 2008-04-30 2009-11-05 Siemens Medical Solutions Usa, Inc. Cyclopeptides containing rgd mimetics as imaging markers for integrins
US8293206B2 (en) 2008-05-30 2012-10-23 Siemens Medical Solutions Usa, Inc. Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment
CA2665302A1 (en) * 2009-05-01 2010-11-01 Universite De Montreal Cd36 modulation and uses thereof
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100297184B1 (ko) * 1992-06-04 2001-10-22 슈테펜엘.네스비트 항혈소판제로서의입체배좌적으로억제된펩타이드동족체및이를포함하는약제학적조성물
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
AU1975695A (en) * 1994-03-04 1995-09-18 Du Pont Merck Pharmaceutical Company, The Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
US5858972A (en) * 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
DE19653036A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate

Also Published As

Publication number Publication date
EP1001979A1 (de) 2000-05-24
US6534478B1 (en) 2003-03-18
KR20010014267A (ko) 2001-02-26
BR9810394A (pt) 2000-09-05
CN1261895A (zh) 2000-08-02
WO1999001472A1 (de) 1999-01-14
ATE297947T1 (de) 2005-07-15
AU733831B2 (en) 2001-05-24
CA2297181A1 (en) 1999-01-14
PL337616A1 (en) 2000-08-28
ID23415A (id) 2000-04-20
DE19728524A1 (de) 1999-01-07
HUP0003357A3 (en) 2001-12-28
SK173599A3 (en) 2000-06-12
AR010924A1 (es) 2000-07-12
JP2002511872A (ja) 2002-04-16
EP1001979B1 (de) 2005-06-15
ZA985896B (en) 1999-06-14
AU8541198A (en) 1999-01-25
NO20000016D0 (no) 2000-01-03
HUP0003357A2 (hu) 2001-02-28
DE59812870D1 (de) 2005-07-21
RU2188205C2 (ru) 2002-08-27
TW482768B (en) 2002-04-11

Similar Documents

Publication Publication Date Title
NO20010203L (no) Diacylhydrazinderivater som integrininhibitorer
NO986090L (no) Fenylalaninderivater som integrininhibitorer
TW372232B (en) Phenylalanine derivatives
SE9704709D0 (sv) Pharmaceutically active compounds
TR200201059T2 (tr) Kardiyak arritmialarının tedavisinde kullanışlı yeni oksabispidin bileşimleri
NO20000841L (no) N-Aroylfenylalanin-derivater
AU2789989A (en) Acylated uridine and cytidine and uses thereof
BR9807345A (pt) Aminoácidos aromáticos biciclicos.
NO20000016L (no) Sykliske azapeptider med angiogen virkning
NO20002702L (no) Tienopyrimidiner
SE8304737D0 (sv) Karbostyrilderivat
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
ATE427107T1 (de) Eine neue verwendung von deferiprone
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
MY136788A (en) 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment or cardiac arrhythmias
NO20020131L (no) Diacylhydrazinderivater
CA2185394A1 (en) Biotinderivate
SE0003795D0 (sv) Pharmaceutically useful compounds
NO20000860L (no) Syklopeptidderivater som adhesjonsinhibitorer
SE9902268D0 (sv) Pharmaceutically active compounds
SE9902270D0 (sv) Pharmaceutically active compounds
NO20020592L (no) Fluorenderivater som integrininhibitorer
SE9902271D0 (sv) Pharmaceutically active compounds
BR0111761A (pt) Composição farmacêutica para o tratamento e/ou profilaxia de uma doença cardìaca em um mamìfero, composto, método para tratar e/ou previnir uma doença cardìaca em um mamìfero

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application